Phase I Trial of GD2.CART Cells Augmented with Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors
Frank Y. Lin,Austin Stuckert,Candise Tat,Mark White,Lucia Ruggieri,Huimin Zhang,Birju Mehta,Natalia Lapteva,Zhuyong Mei,Angela Major,Sachin Thakkar,Thomas Shum,Kathan Parikh,Meng-Fen Wu,Holly B. Lindsay,Lauren Scherer,Meghan Shekar,Patricia Baxter,Tao Wang,Bambi Grilley,Karen Moeller,John Hicks,Angshumoy Roy,Jamie Anastas,Fatema Malbari,Guillermo Aldave,Murali Chintagumpala,Susan Blaney,D. Williams Parsons,Malcolm K. Brenner,Helen E. Heslop,Cliona M. Rooney,Bilal Omer JOURNAL OF CLINICAL ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper